Carregant...
Receptor Discordance of Metastatic Breast Cancer Depending on the Molecular Subtype
INTRODUCTION: Almost 30% of all women with early-stage breast cancer develop metastases. Treatment of metastatic disease is often based on the immunohistochemical information of the primary tumor, despite possible discordance of the hormone and Her2 receptor status. OBJECTIVES: The aim of this study...
Guardat en:
| Publicat a: | Breast Care (Basel) |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
S. Karger GmbH
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7768158/ https://ncbi.nlm.nih.gov/pubmed/33447240 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000506464 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|